Minor Lloyd’s 593‑Share Sale Shows Routine Liquidity, Not a Red FlagMinor Lloyd sells 593 Biogen shares—routine liquidity amid strong insider buying and analyst upgrades, pointing to continued upside potential.BIOGEN INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 05/08/2026, 22:20 3 minutes to read
Biogen Insider Buying Signals Confidence: William A. Hawkins Leads 0.8% Share SurgeBiogen insider buying spikes: William A. Hawkins and execs buy shares post‑Apellis deal, signaling confidence in Biogen’s growth and value potential.BIOGEN INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 12/06/2026, 00:06 4 minutes to read
Biogen Insider Buying: COO Buys 181 Shares Amid Apellis Acquisition & Market VolatilityBiogen insider activity: C.A.O. Sean Godbout buys and sells shares amid Apellis acquisition, revealing cautious optimism and potential upside.BIOGEN INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 03/04/2026, 22:22 3 minutes to read
Biogen CEO’s 54k‑Share Trade Signals Confidence, Not a Market Shake‑UpBiogen CEO’s Feb 6 insider trades show confidence, but routine vesting dominates – a modest 20% stake increase that’s unlikely to sway the market.BIOGEN INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 10/02/2026, 23:22 3 minutes to read
Biogen Insider Buy Signals Confidence Ahead of Earnings – What Investors Must WatchBiogen insider buy signals confidence before earnings; investors weigh this buy with Biogen’s growth prospects and sector trends.BIOGEN INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 03/02/2026, 23:33 5 minutes to read